第　92　巻　索　引,,,
1,,,
16S ribosomal RNA gene sequencing,891,,
A,,,
Achromobacter xylosoxidans,869,,
adjuvant,103,,
AIDS,696,,
amoxicillin,358,386,
antibody,353,,
antimicrobial stewardship,86,,
antimicrobial therapy,115,,
artesunate,690,,
Aspergillus spp.,138,,
avidin-biotin,126,,
B,,,
Bacillus cereus,80,,
bacteremia,133,347,869
bactericidal,670,,
BCG,705,,
β-hemolytic Streptococcus,115,,
blood culture,46,,
C,,,
Campylobacter fetus,884,,
cellulitis,115,,
chlorhexidine-alcohol,46,,
Cholangiosis,371,,
Clostridium botulinum,65,,
colonization,678,,
community acquired methicillin-resistant Staphylococcus aureus,115,686,855
contamination rate,46,,
Cyclospora,371,,
D,,,
dengue fever,61,863,
disinfectant,670,,
disseminated nocardiosis,76,,
E,,,
empyema,891,,
erysipelas,115,,
exfoliative toxin (ET),663,,
F,,,
falciparum malaria,690,,
family,61,,
G,,,
Gemella haemolysans,71,,
genetic testing,331,,
gram stain,76,,
gumma,386,,
H,,,
Haemophilus influenzae,347,,
Helicobacter cinaedi,133,,
hepatitis B virus reactivation,568,,
herpes zoster vaccine,103,,
high-risk patient,51,,
HIV,371,556,
hospital,678,,
I,,,
IgA vasculitis,552,,
immune reconstitution inflammatory syndrome,556,,
immunochromatography,120,126,
incubation period,538,,
infant,65,353,
infant botulism,65,,
infected bulla,376,,
infectious agents surveillance,365,,
infective endocarditis,71,686,
infliximab,878,,
influenza,51,,
inter-professional collaboration,568,,
invasive aspergillosis,556,,
J,,,
Japanese,103,,
Japanese spotted fever,547,,
K,,,
Kawasaki disease,353,,
L,,,
LAMP,701,,
laninamivir,51,,
legal revision,365,,
Legionella,678,,
Legionella pneumonia,701,,
Leptospira Copenhageni,144,,
linen,80,,
long-acting neuraminidase inhibitor,51,,
M,,,
malaria,533,,
malignant lymphoma,133,,
matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS),71,884,
methicillin-resistant Staphylococcus aureus (MRSA),663,,
microscopic agglutination test,144,,
minocycline,547,,
murine typhus,391,,
Mycobacterium goodii,874,,
Mycobacterium haemophilum,878,,
Mycobacterium tuberculosis,705,,
mycotic aortic aneurysm,138,,
N,,,
necrotizing soft-tissue infection,380,,
Nocardia nova,376,,
non-typeable,347,,
norovirus,120,,
nosocomial infection,80,,
O,,,
oral antibiotic therapy,542,,
osteomyelitis,874,,
P,,,
Panton-Valentine leukocidin (PVL),663,,
paratyphoid fever,561,,
Parvimonas micra,891,,
PCR-based open reading frame typing (POT),663,855,
percutaneous lung biopsy,76,,
Plasmodium vivax,538,,
pneumococcal disease,542,,
pregnancy,869,,
prevention,568,,
primary central nervous system lymphoma (PCNSL),696,,
prophylaxis,51,,
public health institutes,365,,
Q,,,
questionnaire,331,,
quinine,690,,
R,,,
rapid diagnostic test (RDT),533,,
rapid growing mycobacteria,874,,
rapid HBsAg screening assay,126,,
real time RT-PCR,120,,
renal angiomyolipoma,869,,
Rheumatoid arthritis,878,,
Rickettia typhi,391,,
S,,,
safety,103,,
SCCmec,686,,
sequence type,855,,
Shewanella haliotis,380,,
Spontaneous Bacterial Peritonitis,884,,
Staphylococcal cassette chromosome mec,855,,
Staphylococcal enterotoxin,552,,
Staphylococcus aureus,552,,
Sub-Saharan Africa,533,,
suspected primary syphilis,386,,
syphilis,358,,
syphilitic,386,,
T,,,
Tokunoshima Island,547,,
toxoplasmic encephalitis,696,,
travel history,538,,
traveller,61,,
tsunami lung,138,,
typhoid fever,391,561,
U,,,
urinary antigen test,701,,
V,,,
vaccine,347,,
vaccine efficacy,103,,
variable number of tandem repeat (VNTR),705,,
vertebral osteomyelitis,542,,
Vi antigen,561,,
virus inactivation,670,,
volunteer,533,,
W,,,
water supply system,678,,
Widal reaction,561,,
Y,,,
Yersinia pseudotuberculosis,353,,
Z,,,
Zika virus infection,863,,